New: Maxis AI Workforce now live across clinical operations.Learn more →

Maxis AI — THE FIRST AI WORKFORCE IN CLINICAL TRIALS
Case Studies Gated Case Study

Case Study

Large CRO: $40–60M Margin Recaptured in FSP Biometrics

Reversing margin erosion through agentic delivery.

Case StudyFebruary 2026Large CRO
Large CRO: $40–60M Margin Recaptured in FSP Biometrics

About this case study

What's inside

Reversing margin erosion through agentic delivery. This case study unpacks the operating model, governance choices, and measured outcomes behind a real customer deployment — written for teams evaluating similar engagements.

Key takeaways

What you'll learn

  • The customer's pre-deployment baseline and target outcomes.
  • How governance was structured before scaling the agentic workflow.
  • Measured improvements in cycle time, cost recovery, and quality KPIs.
  • Lessons learned, including what would be done differently in hindsight.
  • A replicable blueprint for similar sponsor, CRO, or site-network teams.
Dr. Anika Rao

About the author

Dr. Anika Rao

Head of Clinical AI, Maxis AI

Anika leads Maxis AI's clinical agent practice, working with sponsors and CROs on governed deployments across CDM, biometrics, and oversight.

Looking for AI Workforce for clinical trials?

Explore our AI Workforce Platform

See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.

Talk to Experts Explore the Platform